Objective short sleep duration is associated with the activity of the hypothalamic-pituitary-adrenal axis in insomnia;Insônia, com tempo de sono curto, medido objetivamente, esta associada a atividade do eixo hipotálamo-hipófise-adrenal

Arquivos de Neuro-Psiquiatria

Volumn 73, Issue 6, 2015, Pages 516-519

  D’Aurea, Carolina Vicaria R ^a   Poyares, Dalva ^a   Piovezan, Ronaldo D ^a   Passos, Gisele ^a   Tufik, Sergio ^a   de Mello, Marco Tulio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Hypothalamic pituitary adrenal axis; Insomnia disorder; Objective short sleep duration

Indexed keywords

CORTICOTROPIN; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSOMNIA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PILOT STUDY; PITTSBURGH SLEEP QUALITY INDEX; PLETHYSMOGRAPHY; POLYSOMNOGRAPHY; SLEEP TIME; TELEPHONE INTERVIEW; ANALYSIS; BLOOD; CHRONIC DISEASE; DIET RESTRICTION; EPIDEMIOLOGY; GLUCOSE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MIDDLE AGED; PATHOPHYSIOLOGY; REFERENCE VALUE; TIME;

ADRENOCORTICOTROPIC HORMONE; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHRONIC DISEASE; EPIDEMIOLOGIC METHODS; FASTING; FEMALE; GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; POLYSOMNOGRAPHY; REFERENCE VALUES; SLEEP INITIATION AND MAINTENANCE DISORDERS; TIME FACTORS;

EID: 84930980981     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/0004-282X20150053     Document Type: Article

References (28)

1. Ohayon MM, Riemann D, Morin C, Reynolds CF 3rd. Hierarchy of insomnia criteria based on daytime consequences. Sleep Med. 2012;13(1):52-7. http://dx.doi.org/10.1016/j.sleep.2011.06.010
2. National Institutes of Health. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, 13-15 June, 2005. Sleep. 2005;28(9):1049-57.
3. Morin CM, Benca R. Chronic insomnia. Lancet. 2012;379(9821):1129-41. http://dx.doi.org/10.1016/S0140-6736(11)60750-2
4. Fernandez-Mendoza J, Calhoun S, Bixler EO, Pejovic S, Karataraki M, Liao DL. Insomnia with objective short sleep duration is associated with deficits in neuropsychological performance: a general population study. Sleep. 2010;33(4):459-65.
5. Fernandez-Mendoza J, Vgontzas AN, Liao D, Shaffer ML, Vela-Bueno A, Basta M et al. Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension. 2012;60(4):929-35. http://dx.doi.org/10.1161/HYPERTENSIONAHA.112.193268
6. Vgontzas AN; Liao D; Bixler EO; Chrousos GP; Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep. 2009;32(4):491-7.
7. Johansson JK, Kronholm E, Jula AM. Variability in home-measured blood pressure and heart rate: associations with self-reported insomnia and sleep duration. J Hypertens. 2011; 29(10):1897-905. http://dx.doi.org/10.1097/HJH.0b013e32834abccd
8. Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Bixler EO. Insomnia with objective short sleep duration is associated with type 2 diabetes: a population-based study. Diabetes Care 2009;32(11):1980-5. http://dx.doi.org/10.2337/dc09-0284
9. al’Absi M, Arnett DK. Adrenocortical responses to psychological stress and risk for hypertension. Biomed Pharmacother. 2000;54(5):234-44. http://dx.doi.org/10.1016/S0753-3322(00)80065-7
10. Rosmond R, Björntorp P. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med. 2000;247(2):188-97. http://dx.doi.org/10.1046/j.1365-2796.2000.00603.x
11. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab. 2001;86(8):3787-94. http://dx.doi.org/10.1210/jcem.86.8.7778
12. Rodenbeck A, Huether G, Rüther E, Hajak G. Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia. Neurosci Lett. 2002;324(2):159-63. http://dx.doi.org/10.1016/S0304-3940(02)00192-1
13. Riemann D, Klein T, Rodenbeck A, Feige B, Horny A, Hummel R et al. Nocturnal cortisol and melatonin secretion in primary insomnia. Psychiatry Res. 2002;113(1-2):17-27. http://dx.doi.org/10.1016/S0165-1781(02)00249-4
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.
15. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28(2):193-213. http://dx.doi.org/10.1016/0165-1781(89)90047-4
16. Rechtschaffen A, Kales A. Manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Los Angeles: Brain Research Institute, UCLA; 1968.
17. Iber C, Ancoli-Israel S, Chesson AJ, Quan S. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Westchester: American Academy of Sleep Medicine; 2007.
18. Balbo M, Leproult R, Van Cauter E. Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activity. Int J Endocrinol. 2010;2010(2010):ID759234. http://dx.doi.org/10.1155/2010/759234
19. Bonnet MH, Arand DL. 24-Hour metabolic rate in insomniacs and matched normal sleepers. Sleep. 1995;18(7):581-8.
20. Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev. 2013;17(4):241-54. http://dx.doi.org/10.1016/j.smrv.2012.09.005
21. Rodenbeck A, Cohrs S, Jordan W, Huether G, Rüther E, Hajak G. The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks. Psychopharmacology (Berl). 2003;170(4):423-8. http://dx.doi.org/10.1007/s00213-003-1565-0
22. Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33(2):414-20. http://dx.doi.org/10.2337/dc09-1124
23. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435-9. http://dx.doi.org/10.1016/S0140-6736(99)01376-8
24. Castro LS, Poyares D, Leger D, Bittencourt LR, Tufik S. Objective prevalence of insomnia in the São Paulo, Brazil, epidemiologic sleep study. Ann Neurol. 2013;74(4):537-46. http://dx.doi.org/10.1002/ana.23945
25. Jauch-Chara K, Oltmanns KM. Obesity: a neuropsychological disease? Systematic review and neuropsychological model. Prog Neurobiol. 2014;114:84-101. http://dx.doi.org/10.1016/j.pneurobio.2013.12.001
26. Keckeis M, Lattova Z, Maurovich-Horvat E, Beitinger PA, Birkmann S, Lauer CJ. Impaired glucose tolerance in sleep disorders. PLoS One. 2010;5(3):e9444. http://dx.doi.org/10.1371/journal.pone.0009444
27. Gottlieb DJ, Punjabi NM, Newman AB, Resnick HE, Redline S, Baldwin CM et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med. 2005;165(8): 863-7. http://dx.doi.org/10.1001/archinte.165.8.863
28. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep Heart Health Study Investigators. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol. 2004;160(6):521-30. http://dx.doi.org/10.1093/aje/kwh261